GETI-B:STO
Getinge publ AB
SEK 250.30
arrow_upward
+1.58%(+3.90) 1D
Oct 5, 12:43:40 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEK 246.40
High
SEK 250.40
Low
SEK 246.00
Mkt. cap
63.61B
Avg. vol.
570.26K
Volume
72.29K
Dividend
1.90%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.50
52-wk high
SEK 251.40
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEK 246.40
High
SEK 250.40
Low
SEK 246.00
Mkt. cap
63.61B
Avg. vol.
570.26K
Volume
72.29K
Dividend
1.90%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.50
52-wk high
SEK 251.40
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
BigGo Finance
·
53 minutes ago
Warren Buffett's Singular Investment Advice: Own the S&P 500, but Patience Is the Price
Benzinga
·
12 minutes ago
S&P 500 Analyst Optimism Reaches 'Highest Level on Record,' Leaving 'Less Room' for Market Upside, Says C
VT Markets
·
4 hours ago
Week Ahead: Weak US Jobs Shift Fed Outlook as Gold, USD and S&P 500 React
StockStory
·
37 minutes ago
2 S&P 500 Stocks for Long-Term Investors and 1 We Find Risky
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB